Non-thrombotic hematologic manifestations in APS

Wilma Barcellini, Carolina Artusi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Non-thrombotic hematologic manifestations of antiphospholipid syndrome (APS) comprise immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and immune neutropenia, at present not included in APS diagnostic criteria. These cytopenias have been largely reported in APS and share the same underlying pathogenic mechanism mediated by antibodies against blood cells. Thrombocytopenia (platelets 9/L), the most frequent manifestation (20–40 %), is usually mild, although cases with severe bleeding are reported for platelets 9/L. According to published guidelines of primary ITP, treatment is recommended for platelets 9/L, provided that no other bleeding factors are present. First-line treatment includes steroids and intravenous immunoglobulins (IVIG), and second-line treatments of primary ITP splenectomy, rituximab, immunosuppressors, and thrombopoietin (TPO) agonists. However, in APS-associated ITP, immunosuppressors, such as azathioprine, are often the first choice, IVIG are used as second-line treatment, splenectomy is controversial, and TPO agonists are not used. AIHA occurs in about 10 % of APS patients and is clinically heterogeneous, from mild to fulminant life-threatening forms. Conventional therapy of warm AIHA includes corticosteroids as first-line therapy, while immunosuppressive drugs, rituximab, and IVIG are used as second line; steroids are poorly effective in cold forms, whereas rituximab is now recommended as first-line therapy. Last option treatments for refractory cases include plasmapheresis, alemtuzumab, bortezomib, and eculizumab. Both primary ITP and AIHA are associated with thromboembolic events, which should be carefully considered, particularly in the context of APS. The association between leukopenia and antiphospholipid (aPL) antibodies is reported only in few studies, and neutropenia is more frequent in APS secondary to systemic lupus erythematosus.

Original languageEnglish
Title of host publicationAntiphospholipid Antibody Syndrome: From Bench to Bedside
PublisherSpringer International Publishing
Pages113-126
Number of pages14
ISBN (Print)9783319110448, 9783319110431
DOIs
Publication statusPublished - Jan 1 2015

Keywords

  • Autoimmune hemolytic anemia
  • Immune thrombocytopenia
  • Neutropenia

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Non-thrombotic hematologic manifestations in APS'. Together they form a unique fingerprint.

Cite this